Interventional Study Collecting Quantitative and Qualitative Data About Patient With Non Treated Cancer

NCT ID: NCT01647477

Last Updated: 2016-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to determine the impact of sociocognitive and emotional factors on the time of the initial consult

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

identify wich sociocognitive factors influence the delay to go to a doctor after the emergence of first symptoms

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Aerodigestive Tract Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

questionnaires

4 questionnaires to answer at baseline 45 minutes approx.

Group Type ACTIVE_COMPARATOR

questionnaires

Intervention Type BEHAVIORAL

questionnaires to answer at baseline 45 minutes

interview

semi directive interview 105 patients

Group Type EXPERIMENTAL

interview

Intervention Type BEHAVIORAL

25 minutes of semi directive interview

questionnaires

Intervention Type BEHAVIORAL

questionnaires to answer at baseline 45 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

interview

25 minutes of semi directive interview

Intervention Type BEHAVIORAL

questionnaires

questionnaires to answer at baseline 45 minutes

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥ 18 years
* oral cavity cancer, oropharynx cancer, hypopharynx cancer, larynx cancer
* non treated cancer
* patient informed of his diagnosis
* speak fluent french
* patient covered by health insurance
* signed informed consent


* no speech troubles
* patient consents being recorded

Exclusion Criteria

* history of cancer
* psychological history
* patient under guardianship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Oscar Lambret

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Veronique CHRISTOPHE, MDPhD

Role: STUDY_DIRECTOR

Lille 3 University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier

Boulogne-sur-Mer, , France

Site Status

CH

Lens, , France

Site Status

Oscar Lambret Center

Lille, , France

Site Status

Centre Hospitalier Régional et Universitaire - Hopital HURIEZ

Lille, , France

Site Status

La Louviere Hospital

Lille, , France

Site Status

Gray Center

Maubeuge, , France

Site Status

Centre Médical Spécialisé du Littoral

Saint Martin Les Boulogne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DEREDIA - 1110

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.